Iona Walton
A new neurofeedback strategy to treat pain
A novel neurofeedback treatment may help to treat chronic pain in the future, says recent research in Current Biology.
Continue readingGene variations at birth reveal origins of immune disease
Genes identified in cord samples of new babies may explain the origins of chronic immune and inflammatory diseases including rheumatoid arthritis, type 1 diabetes and coeliac disease. It is hoped that these genes can be targeted for therapeutic intervention to stop the diseases in their tracks, well before symptoms occur. Continue reading
Knee osteoarthritis may be successfully treated with thermal nerve radiofrequency ablation
Thermal nerve radiofrequency ablation – when radiofrequency waves are used to ablate (burn) the nerve that is causing pain, eliminating the transmission of pain signals to the brain – seems to be more effective than using painkillers or injections of corticosteroids for knee osteoarthritis. Continue reading
Evidence mounts in favour of electrotherapy in fibromyalgia management
There is growing data regarding the effectiveness of electrotherapy in the management of fibromyalgia-related pain, a research team outlines in Rheumatology International. Continue reading
Anti-nerve growth factor antibodies may relieve osteoarthritis pain and improve function
Blocking nerve growth factor (NGF) with antibodies is a promising strategy for treatment of chronic pain associated with osteoarthritis (OA). Studies have looked at if anti-NGF antibodies can work on osteoarthritis pain and chronic low-back pain, and a group of researchers decided to analyse them to see what trends emerged, reporting their findings in Current Rheumatology Reports. Continue reading
